Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Hepion Pharmaceuticals Inc (HEPA)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Hepion Pharmaceuticals's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
2.040 0.000    0.00%
17/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
2.090
+0.050
+2.451%
8:12:31 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 21,477
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.000 - 2.210
Hepion Pharmaceuticals 2.040 0.000 0.00%

Hepion Pharmaceuticals (HEPA) Earnings Dates & Reports

 
On this page, you can find detailed information about the financial performance of Hepion Pharmaceuticals Inc, including the latest Hepion Pharmaceuticals Inc earnings report and upcoming earnings date. The page provides an overview of the company's financial health, with key data points such as the current stock price, earnings per share, and revenue compared against the forecast.
InvestingPro Earnings Insights
Latest Release

Aug 30, 2023

EPS / Forecast

-- / -2.9

Revenue / Forecast

-- / 0.00

Revenue
EPS
 Forecast
 
Release Date Period End EPS /  Forecast Revenue /  Forecast
Aug 30, 2023 06/2023 -- /  -2.9 -- /  0.00
May 16, 2023 03/2023 -- /  -2.9 -- /  0.00
Mar 01, 2023 12/2022 -1.8 /  -0.12 0.00 /  0.00
Nov 14, 2022 09/2022 -0.11 /  -0.17 0.00 /  0.00
Aug 31, 2022 06/2022 -5.2 /  -0.26 0.00 /  0.00
May 17, 2022 03/2022 -0.09 /  -0.09 0.00 /  0.00
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View upcoming earnings forecasts and in-depth analysis of company forecasts.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

HEPA Comments

Write your thoughts about Hepion Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
stats con chris
stats con chris Jan 26, 2024 8:39PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
2USD fulfilled..unluckily S&P is at record high...which means that a reversal is coming soon and therefore hepion is meant to fall even more..maybe goes from 2 to 3 in a desperate move but global tren will push it to 1. We come back to hepion in july...big month due to presidential elections
Reply
1 0
Report
Chiaretto Calo
Chiaretto Calo Nov 28, 2023 10:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hepion Pharmaceuticals is at the forefront of developing treatments for complex diseases like non-alcoholic steatohepatitis (NASH), fibrotic diseases, hepatocellular carcinoma (HCC), and other chronic conditions. The company uses Artificial Intelligence (AI) to drive its therapeutic drug development, which is a modern approach that could revolutionize treatment methodologies in the medical field. Promising Clinical Trial Results The company's lead drug, Rencofilstat, has shown promising results in the Phase 2 ALTITUDE-NASH clinical trial. This trial achieved primary and secondary endpoints, including improvement in liver function and multiple NASH biomarkers. Additionally, Hepion Pharmaceuticals announced major reductions in liver stiffness with Rencofilstat treatment in a 17-week Phase 2 study of advanced MASH liver disease. These positive outcomes from clinical trials are strong indicators of the drug's potential efficacy and success.
Reply
0 0
Report
stats con chris
stats con chris Jul 25, 2023 6:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Be patient. keep waiting for 2 USD... it will keep going down with fake upward spikes
Reply
0 0
Report
stats con chris
stats con chris May 23, 2023 3:37PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Let's think about it.. When they declared a split the price was 0.7 USD. They needed to hold a 1 USD level to stay in NASDAQ, they needed a +50% growth. They realized that they were not capable of that, which shows that they were aware that their future releases and updates were not going to be sufficient to attrack new investors. Therefore they use a split.. Because of this investors sold their shares and the price fell from 0.7 to 0.5. Then, after the split, it kept falling from 10 to 6, so the real value became 0.3 USD (a disaster). Once real investors sold, insiders and fishy traders decided to buy back the shares up to 20 USD...that is, up to the actual value of 1USD. Because of this alarming price without real suppor for it, now insiders are getting rid of these overvalued stocks selling them to newcomers who think that this is a growing company. Today the price is at 16 USD, that is, around 0.7 USD again. Would they buy more? No way, is an inflated stock, nobody wants to buy an inflated stock without a solid future... Thanks to this move we already know that a good entry point is 6 USD, but due to global consequences it must drop to 2 USD... 2 USD is a good starting point to reset this company from scratch..so until then let's wait
Reply
0 0
Report
stats con chris
stats con chris May 11, 2023 10:04AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Dont buy this... now is at 10 USD after a split 1:20.. real value is 0.5 USD. It will never jump back to 20 USD, HEPA is meant to go back to 2 USD in the future, you will waste money here :D. Every company that splits to remain in NASDAQ fails to increase. of course in the short term it may jump back to 12 or even 15 but the ultimate value in this season is 2 USD... so a total waste....
Reply
1 0
Report
stats con chris
stats con chris May 11, 2023 7:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Split reflects that they don't have money nor good results in the coming months to reach the 0.1USD threshold... In simple terms "they suc$k". Sell their trash. Come back when they are back to 2USD...downtrend is so
Reply
0 0
Report
stats con chris
stats con chris Jan 17, 2023 10:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hepion's comeback
Reply
0 0
Report
Ma Po
Ma Po Jan 17, 2023 10:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
any reason?
Reply
0 0
Report
stats con chris
stats con chris Jan 17, 2023 10:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
they got a nofitication to reach the minium value of 1USD..otherwise they are out of NASDAQ. so they will try to remain above 1... you can read all on their website
Reply
0 0
Report
stats con chris
stats con chris Jan 18, 2022 5:14PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
1.05 is quite delicious :)
Reply
0 0
Report
Serkan Demir
Serkan Demir Jul 26, 2021 3:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Why is it showing 0.627? This stock closed at 1.59.
Reply
0 0
Report
Hoss Cartwright
Hoss Apr 29, 2021 1:25PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Another offering up for vote, bad news
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email